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Transthyretin (TTR) is a circulatory protein which plays an important role in the transport of both thyroid hormone and retinol. Hep G2 cells, 
a human hepatoma-derived cell line. have been used extensively in studies of protein secretion by liver cells. The original description of this cell 
line indicated that this line, unlike primary hepatocytes, does not secrete TTR. We now report studies which reexamine the ability of Hep G2 
cells to synthesize and secrete TTR. For this purpose, total RNA was isolated from Hep G2 cells grown on both uncoated and collagen-coated 
plastic plates and was examined for TTR expression by Northern blot analysis. TTR mRNA was found to be present in nearly equal amounts 
in Hep G2 cells cultured in either condition. When Hep G2 cells were cultured in [z5S]methionine-containing medium. the cells were found both 
to synthesize and to secrete immunoprecipitable f5S]TTR. Hep G2 cells were found, by sensitive and specific radioimmunoassay, to contain 142i91 
ng TTR/l06 cells and to secrete TTR into the medium at a nearly constant rate for at least 24 h after medium change. Our data demonstrate 
that Hep G2 cells do synthesize and secrete TTR and suggest that this cell line might be useful for studies of the secretion of TTR. 
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1. INTRODUCTION 
Plasma transthyretin (TTR) circulates as a 54 980 
dalton tetramer composed of 4 identical subunits [ 1,2]. 
TTR has high affinity binding sites for both thyroxine 
[I ,3,4] and plasma retinal-binding protein (RBP) [4-61; 
hence, TTR plays an important role in the transport of 
both thyroid hormone and retinoi in the circulation. 
Synthesis of TTR occurs primarily in the Iiver and the 
choroid plexus of the brain [7-91, although other tissues 
have been reported to express TTR in much lesser 
amounts [7-l 11. Additionally, neoplastic tissues, in- 
cluding choroid plexus papillomas, glucagonomas, and 
gut carcinomas have been reported to synthesize TTR 
112,131. 
TTR is synthesized with an N-terminal signal peptide 
which is cleaved from the nascent polypeptide in the en- 
doplasmic reticulum (71. At present however, Iittle is 
known regarding how TTR is secreted. For instance, 
very little information is available regarding the possi- 
ble assembly of the 4 TTR subunits within the secretory 
pathway. Docherty et al. [14] have reported studies ex- 
ploring the subunit assembly of TTR in microinjected 
Xenopus oocytes. These authors concluded from their 
studies that liver- and choroid plexus-specific factors 
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may be required for the correct subunit assembly of 
TTR. Other studies exploring the factors which in- 
fluence TTR synthesis and secretion into body fluids 
are also limited. Dixon and Goodman, employing 
isolated and cultured primary rat hepatocytes, demon- 
strated that dexamethasone could maintain TTR secre- 
tion rates, whereas TTR secretion rates, otherwise, were 
observed to decline in untreated primary cultures 
[15,16]. Studies of TTR secretion by cells have been 
limited by the lack of a useful cell line able to synthesize 
and secrete TTR. Hep G2 cells, a human hepatoma- 
derived cell line [ 171, have been used extensively to 
study protein synthesis and secretion [ 1 g-201; however, 
the original report, by Knowles et al. describing this 
line, indicated that Hep G2 cells do not secrete TTR in- 
to the culture medium [17]. While conducting other 
studies with Hep G2 cells, we observed that Hep G2 
cells are indeed able to synthesize and secrete TTR. The 
present report describes our characterization of the syn- 
thesis and secretion of TTR by Hep G2 cells. 
2. MATERIALS AND METHODS 
Hep G2 and Hep 3B cells were obtained from the .American Type 
Culture Collection (RockLille, Maryland, USA). For all of our 
studies, cells were maintained in Dulbecco’% Modified Eagle’s 
Medium (DME) containing IOU- glucose, 10% feral calf serum, and 
peniciliin/streptornycin (100 units each/ml) at 37°C in an atmosphere 
of 8% COZ. All tissue culture reagents wer-e obtained from Gibco 
Laboratories (Grand Island, New York, USA). Cultures of Hep G2 
3. RESULTS 
The original description of Hep cJ2 and Hep 3B cells 
by Knowles et al. indicated that these two hepatoma- 
derived cell line5 do not secrete TTR into the culture 
medium [ 171. There observations were based on the in- 
ability of anti-human TTR antiserum to recognize TTR 
in the culture medium on Ouchterlony double-diffusion 
plates. While carrying out other studies of the anatomic 
sites of RBP expression in human placental tissue, we 
employed total RNA prepared from Hep G2 cells as the 
positive control for RBP expression in our Northern 
blots (since RBP is known to be synthesized by Hep C;2 
cells [ 17,201). Upon stripping our blots and reprobing 
with a cDNA for human TTR, unexpectedly we observ- 
ed a positive signal for TTR in the lanes containing Hep 
C;2 total RNA. This observation led us to undertake a 
systematic characterization of the ability of Hep G2 
cells to synthesize TTR. 
Northern blot analysis of total RNA prepared from 
both Hep G2 and Hep 3B cultures indicates that TTR 
mRNA is present in both of these cell lines. Figure 1 
show Northern blots for TTR mRNA in total RNA 
preparations from 2 cultures each of both Hep G2 and 
Hep 3B cells maintained on uncoated plastic plates and 
from cultures of Hep C;2 ceils maintained on collagen- 
coated plastic plates. It is clear from Fig. 1, that the 
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mRNA is expressed by both Hep Ci2 and Hep 3B cells 
and that the culture of Hep C;2 cells on collagcti-coated 
plates does not markedly influence the level of TTR cl- 
pression in these cells. 
We next asked if Hep G2 cells are able to synthesize 
and secrete TTR. For this purpose, Hcp G2 cells \zere 
metabolically labeled b! cutturin~ them in 
[“Slmcthionine-containing medium. Ne\\Iy synthesized 
TTK was immunoprecipitated with anti-human TTR 
antiserum. The results of thcsc studies arc presented in 
Fig. 2. This figure indicates that [“S]TTR is both syn- 
thesized and secreted by Hep G2 cultures. Cellular 
levels of TTR \\er-e determined by specific RIA fog 
human TTR from 8 plates of Hep C;2 ceils. The mean 
(k SD) Icvel of TTR presenr in these 8 cultures M;\S 142 
7 
-28 kD 





B 800 - 
OVI I I I1 I1 I1 1 I, 1 
0 2 4 6 8 IO 12 14 16 18 20 22 24 26 
Tme, (hrs) 
(+91) ng TTR/lO” cells. The time course of TTR ac- 
cumulation in the Hep G2 culture medium is given in 
Fig. 3. This figure demonstrates that Hep G2 cells 
secrete TTR at a constant rate for at least 24 h after 
change of medium. 
4. DISCUSSION 
The data presented above demonstrate that Hep G2 
cells synthesize and secrete TTR at levels which are 
comparable to those of primary rat hepatocytcs in 
culture. Dixon and Goodman reported that primary rat 
hepatocytes contain approximately 150 ng TTR/lO” 
cells [15,16]. In our studies the mean cellular level of 
TTR in Hep G2 cells was found to be 142 ng TTR/lO” 
cells. Thus, the cellular levels of TTR in primary rat 
hepatocytes and in Hep G2 cells are very similar. 
Primary rat hepatocytes have been reported to secrete 
TTR into the culture medium at a rate of 1.0-I .2 ;lg 
TTR/24 h/lo6 cells [1.5,16]. In our studies of TTR 
secretion by Hep G2 cells, the average rate of accumula- 
tion of TTR in the medium was found to be 1.0 pg 
TTR/24 h/IO” cells. Considering these very similar 
cellular TTR levels and secretion rates and the relatively 
simple procedures needed for the culture of Hep G2 
cells, it would appear that Hep G2 cells might be very 
useful for studies of TTR synthesis and secretion by 
hepatic cells. 
Hep G2 cells have been employed in studies address- 
ing the transcriptional control of the mouse TTR gene 
[26]. If this cell line were to be used in studies of the 
regulation of the human gene, the presence of en- 
dogenous TTR mRNA will need to be taken into con- 
sideration. In addition, Hcp G2 cells have been 
employed to demonstrate receptor mediated uptake of 
FEBS LETTERS Aupst 1901 
TTR [27]. Since the liver is in fact the major organ for 
the catabolism of TTR [28], this cell line may addi- 
tionally be useful for studies addressing’both the syn- 
thesis and the degradation of TTR. 
It is not fully clear to us \vhy previous investigators 
have not detected TTR synthesis in Hep G2 cells. The 
original work by Knowles et al. [17] describing this cell 
line and the lack of TTR accumulation in the culture 
medium employed an insensitive technique (radial im- 
munodiffusion) for detecting TTR presence in the 
culture medium. Later work by Marinari et al. [20], us- 
ing the same radial immunodiffusion techniques, con- 
firmed that TTR could not be detected in the medium 
from Hep G2 cells. We feel it was very likely that these 
radial immunodiffucion assays were too insensitive to 
detect the levels of TTR present in the medium. Neither 
Knowles et al. [17] nor Marinari et al. [20] provide in- 
formation regarding their lower limit of detection for 
TTR in Hep G2 conditioned media. We are not aware 
of any previous studies which examined Hep G2 cells 
for the presence of TTR mRNA. 
Alternatively, it may be possible that we were work- 
ing with an altered variant of the original Hep G2 cells 
described by Knowles et al. [17]. Our cells were obtain- 
ed from the American Type Culture Collection 
(Rockville, MD, USA) and would be representative of 
the Hep G2 cells in this collection. To further pursue the 
possibility that our Hep G2 cells were not a variant Hep 
G2 subclone, we obtained Hep G2 cells from several 
laboratories in the United States and Europe and 
screened them by RIA for the presence of TTR in the 
cells and culture media. Al1 of these different 
laboratory stocks were found both to synthesize and to 
secrete TTR. Although it is not possible to be certain 
that the cells Lvhich we examined were not variants of 
the originally described Hep G2 cells, it is clear that the 
Hep G2 cells used in many laboratories throughout the 
world today, for a variety of studies, synthesize and 
secrete TTR. 
In summary, the studies reported above indicate that 
Hep G2 cells can be used in studies exploring the TTR 
secretory pathway and the factors which influence this 
pathway. Little information is presently available re- 
garding the biochemical factors which regulate and 
direct TTR secretion from the liver. Through the use of 
Hep G2 cultures, studies exploring hepatic secretion of 
TTR can be readily undertaken. In addition, our data 
would indicate that studies exploring possible linkages 
between the TTR and RBP secretory pathways also can 
be undertaken with Hep G2 cells. Such studies might 
provide much useful information regarding both TTR 
secretion and the factors important for RBP secretion 
from the liver. 
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